Atrás
46
Rango del Día
$73.89
$76.09
Rango de 52 Semanas
$62.77
$93.50
Volumen
88,526
Promedio 50D / 200D
$83.01
/
$80.91
Cierre Anterior
$74.70
Quick Summary
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Healthcare (627 pares)
| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 75.7 | 0.3 |
| P/B | 2.4 | 3.0 |
| ROE % | 3.1 | 3.7 |
| Net Margin % | 1.9 | 3.8 |
| Rev Growth 5Y % | 12.1 | 10.0 |
| D/E | 0.9 | 0.2 |
Precio Objetivo de Analistas
Hold
$102.00
+36.1%
P/E Futuro
26.05
EPS Futuro
$2.88
Crecimiento EPS (est.)
+0.0%
Ingresos Est.
838.76M
Estimaciones de Ganancias
| Período | EPS Est. | Ingresos Est. | Analistas |
|---|---|---|---|
| FY2028 |
$3.88
$3.78 – $4.02
|
984.55M | 1 |
| FY2027 |
$3.31
$3.07 – $3.68
|
885.12M | 5 |
| FY2026 |
$2.88
$2.68 – $3.19
|
838.76M | 5 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-25 | $0.68 | $0.67 | -0.7% |
| 2025-11-05 | $0.67 | $0.66 | -1.5% |
| 2025-08-06 | $0.71 | $0.81 | +14.1% |
| 2025-05-07 | $0.46 | $0.48 | +4.3% |
| 2025-02-26 | $0.69 | $0.65 | -5.8% |
| 2024-11-05 | $0.68 | $0.69 | +1.5% |
| 2024-08-13 | $0.81 | $0.73 | -9.9% |
| 2024-05-07 | $0.56 | $0.51 | -8.9% |
Dividend History
7 yr streakYield
0.02%
Payout Ratio
1.82%
Growth (3Y)
3.15%
Growth (5Y)
41.26%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Mar 13, 2026 | Apr 10, 2026 | $0.46 | 2.36% |
| Nov 17, 2025 | Dec 12, 2025 | $0.45 | 2.57% |
| Aug 22, 2025 | Sep 12, 2025 | $0.45 | 2.05% |
| May 23, 2025 | Jun 13, 2025 | $0.45 | 2.41% |
| Mar 14, 2025 | Apr 11, 2025 | $0.45 | 2.31% |
| Nov 15, 2024 | Dec 06, 2024 | $0.44 | 1.96% |
| Aug 23, 2024 | Sep 13, 2024 | $0.44 | 2.06% |
| May 22, 2024 | Jun 14, 2024 | $0.44 | 1.69% |
| Mar 11, 2024 | Apr 05, 2024 | $0.44 | 1.63% |
| Nov 15, 2023 | Dec 08, 2023 | $0.43 | 1.98% |
| Aug 17, 2023 | Sep 08, 2023 | $0.43 | 1.67% |
| May 17, 2023 | Jun 09, 2023 | $0.43 | 1.50% |
| Mar 09, 2023 | Apr 07, 2023 | $0.43 | 1.75% |
| Nov 18, 2022 | Dec 16, 2022 | $0.41 | 1.91% |
| Aug 17, 2022 | Sep 16, 2022 | $0.41 | 1.93% |
| May 13, 2022 | Jun 14, 2022 | $0.41 | 1.51% |
| Mar 11, 2022 | Apr 08, 2022 | $0.41 | 1.61% |
| Nov 12, 2021 | Dec 10, 2021 | $0.38 | 1.46% |
| Aug 19, 2021 | Sep 17, 2021 | $0.38 | 1.00% |
| May 13, 2021 | Jun 11, 2021 | $0.35 | 0.60% |
Puntos Clave
Revenue grew 12.07% annually over 5 years — strong growth
Earnings declined -43.08% over the past year
ROE of 3.12% is below average
Generating 60.99M in free cash flow
P/E of 75.67 — premium valuation
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.26%
Crecimiento
Revenue Growth (5Y)
12.07%
Revenue (1Y)16.33%
Earnings (1Y)-43.08%
FCF Growth (3Y)-8.40%
Calidad
Return on Equity
3.12%
ROIC6.69%
Net Margin1.93%
Op. Margin10.30%
Seguridad
Debt / Equity
0.89
Current Ratio1.01
Interest Coverage8.50
Valoración
P/E Ratio
75.67
Forward P/E26.14
P/B Ratio2.39
EV/EBITDA19.02
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.33% | Revenue Growth (3Y) | 13.64% |
| Earnings Growth (1Y) | -43.08% | Earnings Growth (3Y) | 1.31% |
| Revenue Growth (5Y) | 12.07% | Earnings Growth (5Y) | -14.22% |
| Profitability | |||
| Revenue (TTM) | 780.99M | Net Income (TTM) | 15.06M |
| ROE | 3.12% | ROA | 1.25% |
| Gross Margin | 20.15% | Operating Margin | 10.30% |
| Net Margin | 1.93% | Free Cash Flow (TTM) | 60.99M |
| ROIC | 6.69% | FCF Growth (3Y) | -8.40% |
| Safety | |||
| Debt / Equity | 0.89 | Current Ratio | 1.01 |
| Interest Coverage | 8.50 | ||
| Dividends | |||
| Dividend Yield | 0.02% | Payout Ratio | 1.82% |
| Dividend Growth (3Y) | 3.15% | Dividend Growth (5Y) | 41.26% |
| Consecutive Div Years | 7 yrs | ||
| Valuation | |||
| P/E Ratio | 75.67 | Forward P/E | 26.14 |
| P/B Ratio | 2.39 | P/S Ratio | 1.46 |
| PEG Ratio | -3.45 | Forward PEG | N/A |
| EV/EBITDA | 19.02 | Fwd EV/EBITDA | 12.96 |
| Forward P/S | 1.36 | Fwd Earnings Yield | 3.83% |
| FCF Yield | 5.35% | ||
| Market Cap | 1.14B | Enterprise Value | 1.53B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 780.99M | 671.35M | 604.80M | 553.14M | 495.02M |
| Net Income | 15.06M | 26.46M | 14.67M | 28.27M | 27.82M |
| EPS (Diluted) | 1.42 | 1.84 | 1.28 | 3.34 | 4.49 |
| Gross Profit | 157.34M | 123.92M | 121.51M | 112.02M | 117.18M |
| Operating Income | 80.43M | 63.21M | 52.06M | 56.80M | 70.65M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.20B | 1.17B | 997.24M | 858.15M | 749.43M |
| Total Liabilities | 433.81M | 408.42M | 345.00M | 373.59M | 296.98M |
| Shareholders' Equity | 476.43M | 488.93M | 476.19M | 315.79M | 295.61M |
| Total Debt | 425.74M | 295.23M | 258.59M | 295.34M | 223.08M |
| Cash & Equivalents | 35.57M | 41.36M | 152.83M | 31.59M | 28.57M |
| Current Assets | 139.99M | 137.58M | 233.38M | 111.27M | 95.17M |
| Current Liabilities | 139.04M | 116.28M | 102.19M | 85.49M | 83.48M |
Puntuaciones de Estrategias
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#497 of 1052
Actividad Reciente
Entró
Cash Flow Compounder
Mar 24, 2026